CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.
about
Towards tumor immunodiagnosticsFGFR3-TACC3 fusion in solid tumors: mini reviewImmune checkpoint blockade therapy for bladder cancer treatmentMuscle-invasive urothelial bladder cancer: an update on systemic therapyAdvances in the understanding of cancer immunotherapyTargeting Hsp90 in urothelial carcinomaAn immunologic portrait of cancerDiagnostic biopsy does not commonly induce intratumoral CD8 T cell infiltration in Merkel cell carcinoma.Expression of programmed death-1 ligand (PD-L1) in tumor-infiltrating lymphocytes is associated with favorable spinal chordoma prognosis.Recent advances in treatment of advanced urothelial carcinoma.Immunotherapy in acute leukemiaHigh number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma.Prognostic impact of lymphocytes in soft tissue sarcomasImmune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID micePrognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomasRelationships between tumor microenvironment and clinicopathological parameters in meningiomaImmune regulation of cancerCD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breastControlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumabCD8+ T-cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulationIntratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma.Score Estimating Equations from Embedded Likelihood Functions under Accelerated Failure Time ModelRole of Rip2 in development of tumor-infiltrating MDSCs and bladder cancer metastasis.Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction.Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.The status, limitation and improvement of adoptive cellular immunotherapy in advanced urologic malignanciesTumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityTumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.Smoking-induced immune deviation contributes to progression of bladder and other cancers.Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration.High CD4⁺ T cell density is associated with poor prognosis in patients with non-muscle-invasive bladder cancerCpG expedites regression of local and systemic tumors when combined with activatable nanodelivery.Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma.Trial watch: Prognostic and predictive value of the immune infiltrate in cancerThe association between the recurrence of solitary non-muscle invasive bladder cancer and tumor infiltrating lymphocytesThe predictive value of centre tumour CD8⁺ T cells in patients with hepatocellular carcinoma: comparison with ImmunoscoreFocus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.CCR7 regulates B16 murine melanoma cell tumorigenesis in skinThe prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients
P2860
Q26738691-3DC7DB77-B949-4DE1-A22D-80D84FC1E7C1Q26740578-0D978CA5-8357-4B48-A8DB-34677384D191Q26744139-2EEBA414-5E01-4B57-A1E6-93CE903C324EQ26775780-A41131F7-D75F-4AD2-8CB7-F110FD3ABEB0Q27000706-DA301C84-E42B-43A9-BC7C-0DFC62FC6836Q27023406-BF0143D6-7AC6-4BF4-A87E-CAA1A7887905Q27028000-E0C27E0F-D391-434A-B6E5-38A58CB19168Q31080132-AEBBE50E-FB69-4565-9FEA-29B0912AE4E9Q33276164-FF34CF27-A738-4DE9-B801-5E45649393BAQ33565845-3EE6A1E7-98F6-462C-B701-DFD46CCB80B1Q33731552-0B7AA63C-B019-4B4E-8226-EA7CF818BA8AQ33739931-6860CC9D-2402-4ADB-ACC2-4FF67FCE3875Q33813250-454E055E-D14F-48CB-9705-176AC6CF984CQ34141837-2BF5320C-B04C-40DC-BB20-97772247A5C1Q34178633-DE09978B-4B7F-48AE-AFF1-CBBFDD5A7A4EQ34501928-C009C64D-9DE9-425B-A3A4-1E03E8CD981EQ34586327-1B469C71-8CD9-4BF8-809E-24AE96277582Q34590820-108768A2-42DC-4345-992B-52A35A48985DQ34621713-FF6C3A4B-5907-4CC9-9EF0-8879CF6ECFE7Q34944413-16CC7CFD-4D44-4226-A50A-CA8B92D105ACQ34951157-98858F1D-18A3-4921-96A0-91D72DFA686BQ35049936-1EFF45C0-A005-4966-83FD-4E0F112CA499Q35147988-BF2FCF3B-ECC2-4A78-8219-8132FAD7033DQ35212274-CFDBF418-95E6-4ACC-9AFF-BFCE4E2F8313Q35372913-28131FF3-79A1-4EC6-8C31-5BB0A80372A6Q35538728-205239CE-A8EA-497D-87FA-660B5DAC7630Q35588434-C91F82BA-8878-46A5-8EB5-E594932E727EQ35889643-64F58268-4FC4-4F11-AFE5-7D9BAD93194FQ36060362-2D8FDE50-C1CC-43C5-BC61-E19D5BE7BFBDQ36095397-20D621C0-DFFB-4A6A-B9FA-E44952987EB3Q36215726-5AA63BDE-20E9-4155-B99C-166FAEEC9BE3Q36261897-C44356C3-1226-429F-A7EE-B73B6C0B7DC8Q36395752-30F51B25-CE44-40B6-ACAB-68F721053BECQ36416312-01EA3038-C7EB-4105-9B7E-1EC8BF96B4D9Q36456483-E6880F51-BBDF-4839-B0E6-C914572F82E7Q36522523-74B2A3BA-C28C-4982-B2E7-DB71590C6148Q36546411-A597D372-57F7-4670-9D6A-D7A1382F0223Q36860110-6779E981-0856-4C74-AA43-8FE985EA654CQ36882300-65782C2E-E9FF-402A-AEB1-263F22CAEE84Q36946671-EC5DCADB-DF58-497A-8242-47DBCBCE2994
P2860
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
CD8 tumor-infiltrating lymphoc ...... invasive urothelial carcinoma.
@ast
CD8 tumor-infiltrating lymphoc ...... invasive urothelial carcinoma.
@en
type
label
CD8 tumor-infiltrating lymphoc ...... invasive urothelial carcinoma.
@ast
CD8 tumor-infiltrating lymphoc ...... invasive urothelial carcinoma.
@en
prefLabel
CD8 tumor-infiltrating lymphoc ...... invasive urothelial carcinoma.
@ast
CD8 tumor-infiltrating lymphoc ...... invasive urothelial carcinoma.
@en
P2093
P2860
P356
P1476
CD8 tumor-infiltrating lymphoc ...... invasive urothelial carcinoma.
@en
P2093
Achim A Jungbluth
Dean F Bajorin
Eiichi Sato
Harry Herr
Lloyd J Old
Padmanee Sharma
Sacha Gnjatic
Sachiko Yamada
Victor E Reuter
P2860
P304
P356
10.1073/PNAS.0611618104
P407
P577
2007-02-27T00:00:00Z